Evaluation and Validation of New Biomarkers by Mass Spectrometry

A New Approach by Mass Spectrometry for Evaluation and Validation of New Biomarkers of Fetus and Mother

The investigators will perform biochemical and metabolic evaluations on cord blood, venous blood of the mother and urine of the foetus and mother using time-of-flight and tandem mass spectrometry. The investigators could evaluate, dose and validate gestational diabetes mellitus biomarkers of the fetus and mother.

Inclusion Criteria:

For women:

• Aged 18 or more
• 24 weeks of gestation or more
• Type 1, type 2 or gestational diabetes mellitus for group 1
• Without diabetes for group 2.

For newborn:

• 37 weeks of gestation or more
• Birth weight 2500 g or more

Exclusion Criteria:

• Multiple birth